Revenue: The sum of all revenue fields included for a company's operating activities.
GT Biopharma, Inc. (GTBP) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-7.52M |
|
-- |
|
-- |
|
$5.59M |
|
$-5.59M |
|
$-0.11M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.59M |
|
$-5.59M |
|
5.51M |
|
5.51M |
|
$3.53 |
|
$3.53 |
|
| Balance Sheet Financials | |
$8.11M |
|
-- |
|
-- |
|
$8.11M |
|
$2.32M |
|
-- |
|
-- |
|
$2.32M |
|
$5.79M |
|
$5.79M |
|
$5.79M |
|
25.53M |
|
| Cash Flow Statement Financials | |
$-12.91M |
|
-- |
|
$15.78M |
|
$4.04M |
|
$6.91M |
|
$2.86M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-98.65% |
|
-98.63% |
|
-70.42% |
|
-98.63% |
|
$0.23 |
|
$-2.34 |
|
$-2.34 |
|